5369 篇
13901 篇
477602 篇
16255 篇
11755 篇
3914 篇
6522 篇
1248 篇
75548 篇
37648 篇
12140 篇
1653 篇
2850 篇
3411 篇
641 篇
1239 篇
1972 篇
4909 篇
3866 篇
5438 篇
全球溶酶体贮积症市场报告(2014-2018年)
Global Lysosomal Storage Diseases Market 2014-2018
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
Product Portfolio
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 First Approved Drugs for Treatment of Lysosomal
Storage Diseases
07.4 Five Forces Analysis
08. Market Segmentation by Drug Class
08.1.1 ERTs
08.1.2 SRT
08.1.3 Cystine Depletors
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.2.1 Genzyme
17.2.2 Shire
17.2.3 BioMarin Pharmaceutical
17.2.4 Actelion Pharmaceuticals
17.2.5 Others
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Actelion Pharmaceuticals
18.1.1 Business Overview
18.1.2 Key Information
18.1.3 SWOT Analysis
18.2 BioMarin Pharmaceutical 2
18.2.1 Business Overview
18.2.2 Key Information
18.2.3 SWOT Analysis
18.3 Genzyme
18.3.1 Business Overview
18.3.2 Key Information
18.3.3 SWOT Analysis
18.5 Shire
18.5.1 Business Overview
18.5.2 Key Information
18.5.3 SWOT Analysis
19. Other Reports in this Series